insights_auto
Why is HLUBF up 5.16%?
Dive Deeperchevron_right
HLUBF:OTCMKTS
H Lundbeck A/S Class A
$8.35
arrow_upward
+5.16%(+0.41) 1D
Nov 12, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUBF...
Open
$8.35
High
$8.35
Low
$8.35
Mkt. cap
60.82B
Avg. vol.
113.00
Volume
150.00
52-wk high
$8.35
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
Open
$8.35
High
$8.35
Low
$8.35
Mkt. cap
60.82B
Avg. vol.
113.00
Volume
150.00
52-wk high
$8.35
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
News stories
From web sources and news partners
TradingView
·
14 hours ago
H. Lundbeck Q3 2026 Earnings Call Is Live
Morningstar
·
21 hours ago
Strong Demand For Vyepti Drives Improved Near-Term Outlook For Lundbeck
GuruFocus
·
1 day ago
H. Lundbeck AS (HLUBF) (Q3 2026) Earnings Call Highlights: Raised Guidance and Strong Vyepti Momentum
Investing.com
·
1 day ago
Earnings call transcript: Lundbeck lifts 2026 outlook on strong Q3 growth
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5K
Founded1915
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitelundbeck.com